Bringing named-patient and specialist rare-disease therapies to the patients who need them
Reliably, and with the access expertise rare disease demands. From enzyme-replacement and complement therapies to one-time gene therapy — sourced through the right access pathway, every time.
A single, accountable route to verified healthcare access. Medserv Africa and TheDOTMED bring institutions one dependable partner for the complete rare disease & orphan therapies formulary — verified, registration-checked and delivered on time, so your teams can focus on patients, not procurement.
Complete therapeutic coverage
46 verified SKUs spanning 6 access pathways — the breadth your institution needs, from one accountable source.
Supplied across the whole pathway
From first presentation to ongoing care, your formulary is covered at every stage — no gaps, no scrambling for an alternate supplier.
Service levels you can plan around
We hold ourselves to clear, measurable standards — so essential therapy is there when your patients need it.
Service levels shown are illustrative target standards and are agreed per institution in the supply agreement.
Verified before it ever reaches your shelf
Every product in the rare disease & orphan therapies formulary passes a documented verification standard.
"Verified access, accountable route, audit-ready evidence" is not a slogan — it is the operating standard we hold for every line we supply to your institution.
A partnership, not just a price list
From onboarding to ongoing review, we work alongside your procurement and clinical teams.
Let's build your complete rare disease & orphan therapies formulary together
One accountable partner. Verified quality. Dependable supply. Talk to us about a formulary partnership tailored to your institution.